Filters close
access_time Embargo lifts in 2 days
This news release is embargoed until 19-Mar-2024 10:00 AM EDT Released to reporters: 18-Mar-2024 7:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-Mar-2024 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Glaucoma Research Foundation Releases Informational Audiobook for Glaucoma Patients in Collaboration with Braille Institute of America
Released: 18-Mar-2024 7:05 PM EDT
Glaucoma Research Foundation Releases Informational Audiobook for Glaucoma Patients in Collaboration with Braille Institute of America
Glaucoma Research Foundation

The free glaucoma audiobook, narrated by Bianca Beach, is available for patients and their families to listen, download, and share.

Released: 18-Mar-2024 5:05 PM EDT
UC Irvine-led research team discovers role of key enzymes that drive cancer mutations
University of California, Irvine

A research team led by the University of California, Irvine has discovered the key role that the APOBEC3A and APOBEC3B enzymes play in driving cancer mutations by modifying the DNA in tumor genomes, offering potential new targets for intervention strategies.

Newswise: Hackensack Meridian Jersey Shore University Medical Center Welcomes Dr. Lee Peng as Chief of Gastroenterology
Released: 18-Mar-2024 5:05 PM EDT
Hackensack Meridian Jersey Shore University Medical Center Welcomes Dr. Lee Peng as Chief of Gastroenterology
Hackensack Meridian Health

Hackensack Meridian Jersey Shore University Medical Center welcomed Lee F. Peng, M.D., PhD, as section chief of gastroenterology, department of medicine.

Not for public release

This news release is embargoed until 18-Mar-2024 5:00 PM EDT Released to reporters: 12-Mar-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Mar-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: A New Study Shows How Neurochemicals Affect fMRI Readings
Released: 18-Mar-2024 4:05 PM EDT
A New Study Shows How Neurochemicals Affect fMRI Readings
University of North Carolina School of Medicine

A landmark study, led by Yen-Yu Ian Shih, PhD, at the UNC School of Medicine, shows how neurochemicals can influence blood vessels. The new findings may alter how researchers interpret results from functional magnetic resonance imaging.

Released: 18-Mar-2024 4:05 PM EDT
تنبيه من خبير: تطورات في جراحة استبدال الركبة تمنح خيارات مبتكرة للمرضى
Mayo Clinic

تدفع فئة السكان المتقدمين في العمر الطلب العالمي لجراحة استبدال الركبة، بما يتجاوز مليون إجراء طبي سنويًا. في هذا المقال، يصف الدكتور تشارلز هانون، دكتور في الطب، جرّاح العظام في مايو كلينك في روتشستر، ابتكارات مثل الأدوات المتقدمة والجراحة الروبوتية الدقيقة التي تعمل على تحسين عملية استبدال الركبة بالكامل للمرضى.

Released: 18-Mar-2024 3:45 PM EDT
Two-Day Course Teaches Hospitals and Health Systems How to Address Unprofessionalism and Unsafe Behavior
Vanderbilt University Medical Center

The Vanderbilt Health Center for Patient and Professional Advocacy (CPPA) will host a two-day, hands-on course in Nashville to equip hospital and health system leaders with strategies and tools to address unprofessionalism and create a safe, respectful and reliable environment inside their organizations.

Released: 18-Mar-2024 3:05 PM EDT
Text nudges can increase uptake of COVID-19 boosters– if they play up a sense of ownership of the vaccine
University of California, Los Angeles (UCLA), Health Sciences

Text nudges encouraging people to get the COVID-19 vaccine, which had proven effective in prior real-world field tests, are also effective at prompting people to get a booster. The key in both cases is to include in the text a sense of ownership in the dose awaiting them.

Newswise: Role in mitochondrial metabolism paints more complete picture of MCL-1 function
Released: 18-Mar-2024 3:05 PM EDT
Role in mitochondrial metabolism paints more complete picture of MCL-1 function
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital have uncovered a metabolic role for cell-survival protein MCL-1, potentially explaining previous clinical trial setbacks.

Released: 18-Mar-2024 3:05 PM EDT
Memorial Sloan Kettering Awarded Prestigious NCI Grant to Further Advance CAR T Cell Treatments for Solid Tumors
Memorial Sloan Kettering Cancer Center

A team at Memorial Sloan Kettering Cancer Center (MSK) led by thoracic surgeon Prasad Adusumilli, MD, has been awarded a distinguished UG3/UH3 grant from the National Cancer Institute (NCI) to advance research and testing of chimeric antigen receptor (CAR) T cell therapy for solid tumors.

access_time Embargo lifts in 2 days
This news release is embargoed until 20-Mar-2024 4:00 PM EDT Released to reporters: 18-Mar-2024 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Mar-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Researchers Call for Regulation of Direct-to-Consumer Microbiome Tests
Released: 18-Mar-2024 2:05 PM EDT
Researchers Call for Regulation of Direct-to-Consumer Microbiome Tests
University of Maryland, Baltimore

Scientific research has linked a person’s microbiome to everything from gut and mental health to immunity and predisposition to cancer.

Not for public release

This news release is embargoed until 18-Mar-2024 2:05 PM EDT Released to reporters: 18-Mar-2024 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Mar-2024 2:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Cleveland Clinic-Led Research Concludes Video Laryngoscopy is Most Effective Method for Intubating Patients Undergoing Surgical Procedures
Released: 18-Mar-2024 1:25 PM EDT
Cleveland Clinic-Led Research Concludes Video Laryngoscopy is Most Effective Method for Intubating Patients Undergoing Surgical Procedures
Cleveland Clinic

New Cleveland Clinic-led research provides evidence that video laryngoscopy significantly decreased the number of attempts needed to achieve intubation in adult surgical patients who required single-lumen endotracheal intubation for general anesthesia, compared with direct laryngoscopy. The research was published today in JAMA.

Released: 18-Mar-2024 1:05 PM EDT
Alerta dos especialista: Avanços na cirurgia de artroplastia do joelho oferecem opções aos pacientes
Mayo Clinic

O envelhecimento da população impulsiona a demanda global pela cirurgia de artroplastia do joelho, excedendo a 1 milhão de procedimentos anuais.

Released: 18-Mar-2024 1:00 PM EDT
Dana-Farber Cancer Institute Launches Neuro-Inclusive Oncology Care and Empowerment Program
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute launched the Neuro-Inclusive Oncology Care and Empowerment Program, a psychosocial oncology program that is specialized for adults with intellectual and/or developmental disabilities (IDD).

Newswise: Johns Hopkins Medicine-Led Team Develops Fluid Biomarker for Early Detection of ALS and FTD
Released: 18-Mar-2024 1:00 PM EDT
Johns Hopkins Medicine-Led Team Develops Fluid Biomarker for Early Detection of ALS and FTD
Johns Hopkins Medicine

Two progressively degenerative diseases, amyotrophic lateral sclerosis (ALS, commonly known as Lou Gehrig’s disease) and frontotemporal dementia (FTD, recently in the news with the diagnoses of actor Bruce Willis and talk show host Wendy Williams), are linked by more than the fact that they both damage nerve cells critical to normal functioning — the former affecting nerves in the brain and spinal cord leading to loss of movement, the latter eroding the brain regions controlling personality, behavior and language.

Newswise: Hackensack Meridian Health Foundation Awarded “High Performer” Designations by the Association for Healthcare Philanthropy
Released: 18-Mar-2024 12:15 PM EDT
Hackensack Meridian Health Foundation Awarded “High Performer” Designations by the Association for Healthcare Philanthropy
Hackensack Meridian Health

Hackensack Meridian Health Foundation Awarded “High Performer” Designations by the Association for Healthcare Philanthropy

Released: 18-Mar-2024 12:05 PM EDT
Alerta de los expertos: Los avances en la cirugía de reemplazo de rodilla ofrecen opciones a los pacientes
Mayo Clinic

El envejecimiento de la población impulsa la demanda mundial de cirugía de reemplazo de rodilla, superando el millón de procedimientos anuales.

Released: 18-Mar-2024 11:30 AM EDT
Study Estimates Nearly 70 Percent of Children Under Six in Chicago May Be Exposed to Lead-Contaminated Tap Water
Johns Hopkins Bloomberg School of Public Health

A new analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health estimates that 68 percent of Chicago children under age six live in households with tap water containing detectable levels of lead.

Released: 18-Mar-2024 11:05 AM EDT
Don’t Delay Vaccines—They Are Safe, Effective and Save Lives
Children's Hospital Los Angeles

Vaccine misinformation has gone mainstream—a post-pandemic reality that is putting more children at risk of exposure to potentially serious vaccine-preventable diseases like measles.

Released: 18-Mar-2024 10:05 AM EDT
Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study
University of California, Los Angeles (UCLA), Health Sciences

A team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combination of a short course of powerful and intense hormonal therapy with targeted radiation is safe and effective in treating people with prostate cancer that has come back and has spread to other parts of the body.

Newswise: Hackensack Meridian Health’s New Primary Care Practice in Fort Lee, NJ,

Expands Access to Expert, Multilingual Medical Care for Bergen County Residents
Released: 18-Mar-2024 10:05 AM EDT
Hackensack Meridian Health’s New Primary Care Practice in Fort Lee, NJ, Expands Access to Expert, Multilingual Medical Care for Bergen County Residents
Hackensack Meridian Health

Hackensack Meridian Health has opened a new primary care practice in Fort Lee, expanding access to expert, multilingual medical care for patients of all ages in Bergen County.

Newswise: Newly identified yeast could prevent fungal infections by outcompeting rivals, study suggests
11-Mar-2024 10:05 AM EDT
Newly identified yeast could prevent fungal infections by outcompeting rivals, study suggests
The Rockefeller University Press

Researchers at the Weizmann Institute of Science in Israel have identified a yeast that could be used to prevent invasive candidiasis, a major cause of death in hospitalized and immunocompromised patients. The study, to be published March 18 in the Journal of Experimental Medicine (JEM), shows that the novel yeast lives harmlessly in the intestines of mice and humans and can displace the yeast responsible for candidiasis, Candida albicans.

Released: 18-Mar-2024 9:05 AM EDT
SHRO and Temple Create iNest to Commercialize Innovations
Sbarro Health Research Organization (SHRO)

With funding from the Commonwealth of Pennsylvania and the Sbarro Health Research Organization (SHRO), the latest incubator and technology transfer institute opens at Temple University.

Released: 18-Mar-2024 9:05 AM EDT
American Society of Nephrology and Home Dialysis University Expand Collaboration to Enhance Home Therapies Education for Nephrology Fellows
American Society of Nephrology (ASN)

The American Society of Nephrology (ASN) and Home Dialysis University (HDU) launched a collaboration in 2023 to improve nephrology trainees’ knowledge, proficiency, and exposure to home dialysis therapies.

Newswise: Case Western Reserve University researchers report rise in global fungal drug-resistant infections
Released: 18-Mar-2024 9:00 AM EDT
Case Western Reserve University researchers report rise in global fungal drug-resistant infections
Case Western Reserve University

A global wave of infections caused by fungi growing drug-resistant has the medical community issuing precautions on how to protect yourself.

access_time Embargo lifts in 2 days
This news release is embargoed until 25-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Mar-2024 9:00 AM EDT
St. Baldrick’s Foundation Awards $50,000 Grant to Expand Pediatric Cancer Clinical Trials at K. Hovnanian Children’s Hospital
Hackensack Meridian Health

St. Baldrick’s Foundation Awards $50,000 Grant to Expand Pediatric Cancer Clinical Trials at K. Hovnanian Children’s Hospital

access_time Embargo lifts in 2 days
This news release is embargoed until 24-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 26-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 25-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 24-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 25-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 25-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 23-Mar-2024 1:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Mar-2024 1:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 25-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Managing Kids’ Seasonal Allergies Is Nothing to Sneeze at — Johns Hopkins Children’s Center Experts Available for Interviews
Released: 18-Mar-2024 9:00 AM EDT
Managing Kids’ Seasonal Allergies Is Nothing to Sneeze at — Johns Hopkins Children’s Center Experts Available for Interviews
Johns Hopkins Medicine

Spring will soon be in bloom, bringing runny and stuffy noses, sneezes and itchy, watery eyes.

access_time Embargo lifts in 2 days
This news release is embargoed until 24-Mar-2024 5:30 PM EDT Released to reporters: 18-Mar-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Mar-2024 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

13-Mar-2024 11:30 AM EDT
Middle-aged Americans lonelier than European counterparts
American Psychological Association (APA)

Middle-aged adults in the U.S. tend to report significantly higher levels of loneliness than their European counterparts, possibly due in part to weaker family ties and greater income inequality, according to research published by the American Psychological Association.

   
Newswise: Breakthrough Discovery: Stem Cell
Released: 18-Mar-2024 8:05 AM EDT
Breakthrough Discovery: Stem Cell "Messages" Fast-Track Healing of Diabetic Wounds
Chinese Academy of Sciences

A study has unveiled that exosomes, extracted from adipose mesenchymal stem cells (ADSC-Exos), markedly speed up the healing process of skin wounds in diabetic mice. This discovery tackles the pressing global health issue of diabetic wounds, notorious for precipitating grave complications and impairments.

Newswise: Yale Cancer Center experts present new research on obesity, tobacco, evolution, and early onset cancers at leading oncology conference
Released: 18-Mar-2024 7:00 AM EDT
Yale Cancer Center experts present new research on obesity, tobacco, evolution, and early onset cancers at leading oncology conference
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.

Newswise:Video Embedded artificial-mucus-identifies-link-to-tumor-formation
VIDEO
11-Mar-2024 11:45 PM EDT
Artificial mucus identifies link to tumor formation
American Chemical Society (ACS)

Mucus is critical to human health. To explore how, researchers synthesized its major component, sugar-coated proteins called mucins, and discovered that changing the mucins of healthy cells to be more cancer-like made cells act more cancer-like. They will present their results at ACS Spring 2024.

   
Newswise:Video Embedded mimicking-exercise-with-a-pill
VIDEO
11-Mar-2024 11:45 PM EDT
Mimicking exercise with a pill
American Chemical Society (ACS)

Could a pill replicate the benefits of exercise? Researchers have identified new compounds that seem to mimic some benefits of exercise in rodent cells. This discovery could help treat those with muscle wasting and other conditions. The scientists will present their results at ACS Spring 2024.

   


close
1.32876